Averna Therapeutics Inc. — Form D/A

Averna Therapeutics Inc. of WATERTOWN, MA, a company, filed a Form D amendment with the SEC on 2025-04-21. The offering totals $85.0M, of which $43.8M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Roy AmariglioDirectorWatertown, MA
Thomas Barnes, Ph.D.DirectorWatertown, MA
Henry ChenDirectorBEDFORD, MA
DYLAN MORRISDirectorWatertown, MA
Aaron NelsonDirectorNEW YORK, NY
Raju Prasad, Ph.D.DirectorWatertown, MA
Stephen SquintoDirectorStamford, CT
Tal Zaks, M.D., Ph.D.DirectorWatertown, MA
Thomas Barnes, Ph.D.Executive OfficerWatertown, MA
Anat NursellaExecutive OfficerWatertown, MA
Tal Zaks, M.D., Ph.D.Executive OfficerWatertown, MA
Henry ChenRelated PersonBEDFORD, MA
Stephen SquintoRelated PersonStamford, CT
Nick OlsenDirectorWatertown, MA
Nick OlsenRelated PersonWatertown, MA
DYLAN MORRISRelated PersonWatertown, MA
Roy AmariglioExecutive OfficerWatertown, MA
Roy AmariglioRelated PersonWatertown, MA
Tal ZaksDirectorWatertown, MA
Tal ZaksExecutive OfficerWatertown, MA
Tal ZaksRelated PersonWatertown, MA
Michal SilverbergDirectorWatertown, MA
Michal SilverbergRelated PersonWatertown, MA
Alex HardingDirectorNew York, NY
Richard MorrisExecutive OfficerWatertown, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2026-03-20D/A$85.0M$85.0M
2024-04-17D$85.0M$38.8M

More